by Danielle Bonadies | Mar 26, 2015 | Genetic Journal
Following Angelina Jolie Pitt’s disclosure earlier this week that she recently underwent a prophylactic bilateral salpingo-oophorectomy, we held an impromptu Tweet chat to discuss hereditary cancer and risk management. The BRCA community has...
by Danielle Bonadies | Dec 1, 2014 | Genetic Journal
It is well-known that women who carry a mutation in BRCA1 or BRCA2 are at high risk to develop breast cancer (50-85% lifetime risk) and ovarian cancer (15-60% lifetime risk). Because the screening options for ovarian cancer (transvaginal ultrasound, the blood test...
